In today's era of information explosion, how to accurately grasp market dynamics and gain insight into industry trends has become the focus of common attention of enterprises and investors. To this end, the "2024-2030 China Genetic Testing Industry Market Special Research and Investment Prospect Research Report" created by the Zhiyan Consulting and Analysis Team aims to provide the most researchable and practical industry analysis for elites from all walks of life.
This report brings together the collective wisdom of the research team of Zhiyan Consulting, combined with authoritative data at home and abroad, and deeply analyzes the development status, competition pattern and future trend of the genetic testing industry. We uphold a professional and rigorous research attitude, and strive to present a clear and three-dimensional picture of the industry to readers through multi-dimensional and all-round data analysis.
In terms of content, the report not only covers an in-depth interpretation of the industry, but also conducts a nuanced discussion of the genetic testing industry. Whether it is the policy environment, market demand, or technological innovation, capital operation, we have carried out detailed elaboration and unique analysis. In addition, we pay special attention to the leading companies in the industry, and provide an in-depth analysis of their success stories and market strategies.
Genetic testing refers to a method in which the genes of the tested person are extracted from blood, body fluids or tissue specimens, and the type, defects and expression ability of genes are analyzed by using primers and advanced molecular biotechnology that can distinguish possible mutant genes, so as to determine the type of genes and gene defects they contain, as well as whether their expression function is normal. At present, according to the application field of genetic testing, genetic testing in mainland China is mainly divided into three types: scientific research-grade genetic testing, clinical-grade genetic testing and consumer-grade genetic testing.
In recent years, with the continuous development of genetic testing technology and the expansion of the scope of application, the scale of the mainland genetic testing market has maintained a rapid growth rate. The size of the mainland genetic testing market will increase from 14.9 billion yuan in 2019 to 23.1 billion yuan in 2022, with an average annual compound growth rate of 15.7%; The market size in 2023 will be about 29.7 billion yuan, a year-on-year increase of 28.6%.
The upstream of the genetic testing industry chain is mainly the supply of genetic testing equipment and consumables and reagents; The middle of the industrial chain is a provider of genetic testing services; The downstream of the industrial chain is the application field of genetic testing. The upstream of the industrial chain mainly provides gene sequencing platforms and solutions for the genetic testing industry, while the downstream is mainly medical institutions, scientific research institutions, pharmaceutical companies and individual users.
Manufacturers in China's genetic testing industry are mainly concentrated in first-tier cities such as Beijing, Shanghai, Guangzhou, and Shenzhen, as well as some developed cities along the eastern coast. These areas have a high level of science and technology, abundant medical resources, a complete industrial chain and good policy support, which provides a good environment for the development of genetic testing enterprises. It mainly includes Hongbo Gene and Boao Biotechnology in Beijing; WuXi AppTec in Jiangsu Province; Dian Diagnostics in Zhejiang Province; Maccura Biotech and Berry Gene in Sichuan Province; Enterprises such as Da'an Gene and BGI in Guangdong Province.
As a professional organization that has witnessed the development of genetic testing in China for more than ten years, Zhiyan Consulting hopes to work together with all enterprises committed to the genetic testing industry to provide more effective information, professional consulting and personalized customized industry solutions, and make a modest contribution to the development of the industry.
Data Description:
1: The core data of this report has been updated to December 2023 (the relevant financial indicators of non-listed companies in the report are affected by corporate credit approval, and there may be a certain lag), and the forecast period of the report is 2024-2030.
2: In addition to the first-hand research information and data, authoritative data sources such as the National Bureau of Statistics, China Customs, industry associations, and public reports of listed companies (prospectuses, transfer prospectuses, annual reports, inquiry reports, etc.) also constitute the data sources of this report. The first-hand data comes from the first-hand information data obtained by the research team from interviews with key enterprises in the industry, and the main interview subjects include corporate executives, industry experts, technical leaders, downstream customers, distributors, agents, distributors and upstream raw material suppliers. Secondary sources mainly include relevant industry news, company annual reports, non-profit organizations, industry associations, government agencies and third-party databases from around the world.
3: The core data of the report is based on the strict data collection, screening, processing, analysis system and independent calculation model of the Zhiyan team to ensure the accuracy and reliability of statistical data.
4: The data used in this report are all from compliance channels, and the analysis logic is based on the professional understanding of the Zhiyan team, which clearly and accurately reflects the research views of analysts.
As a leading brand in the field of industrial consulting in China, Zhiyan Consulting takes "driving industrial development with information and empowering enterprise investment decision-making" as its brand concept. The company integrates quantitative analysis and qualitative analysis methods, uses self-developed algorithms, combines industry cross-big data, and excavates the root causes behind quantitative data through diversified analysis, analyzes the logic behind qualitative content, objectively and truthfully explains the current situation of the industry, prudently predicts the future development trend of the industry, and provides customers with professional industry analysis, market research, data insights, strategic consulting and related solutions to help customers improve their cognitive level, profitability and comprehensive competitiveness. The main services include high-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, industrial planning, etc. Provide weekly/monthly/quarterly/annual reports and other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.
Table of Contents:
Chapter 1 Basic Overview of the Genetic Testing Industry
1.1 Overview of genes
1.1.1 Definition of genes
1.1.2 Classification of genes
1.1.3 Relationship between genes and diseases
1.1.4 Application of gene technology
1.2 Overview of genetic testing
1.2.1 Definition of genetic testing
1.2.2 Basic Principles of Genetic Testing
1.2.3 Application direction of genetic testing
1.3 Analysis of the genetic testing industry chain
1.3.1 Overview of the industrial chain
1.3.2 Upstream of the industrial chain
1.3.3 Midstream of the industrial chain
1.3.4 Downstream of the industrial chain
Chapter 2 Analysis of the development of the international genetic testing industry from 2019 to 2023
2.1 Overview of the development of the international genetic testing industry
2.1.1 Industry development drivers
2.1.2 Distribution of industry application fields
2.1.3 Industry market development trends
2.1.4 Gene expression analysis market
2.1.5 Status quo of accreditation of genetic testing services
2.1.6 Analysis of capital market operation
2.2 Development of genetic testing industry in United States
2.2.1 Government support
2.2.2 Industry development trends
2.2.3 Industry regulatory dynamics
2.2.4 Progress of technical approval
2.3 Development of the genetic testing industry in other regions
2.3.1 France
2.3.2 United Kingdom
2.3.3 Japan
2.3.4 Russia
2.3.5 India
Chapter 3 Analysis of the development environment of China's genetic testing industry from 2019 to 2023
3.1 Economic Environment
3.1.1 Global Economic Situation
3.1.2 Operation of the national economy
3.1.3 Investment in fixed assets
3.1.4 Macroeconomic outlook
3.2 Policy Environment
3.2.1 Context of policy development
3.2.2 Support from industry bodies
3.2.3 Technology policy orientation
3.2.4 Regulatory policy analysis
3.3 Social Environment
3.3.1 Population size and composition
3.3.2 Characteristics of tumor disease development
3.3.3 Increased incidence of complex diseases
3.3.4 Genetic testing and medical insurance
3.3.5 Socio-ethical discussions of genes
3.4 Technical Environment
3.4.1 Overview of the development of genetic testing technology
3.4.2 Big data helps genetic testing
3.4.3 Development of nano-gold probe technology
3.4.4 Advances in electrochemiluminescence technology
Chapter 4 A Comprehensive Analysis of the Development of China's Genetic Testing Industry from 2019 to 2023
4.1 Overview of the development of the genetic testing industry
4.1.1 The importance of the development of the genetic testing industry
4.1.2 Advantages of genetic testing to prevent tumor risk
4.1.3 Advantages of genetic testing for Down syndrome
4.1.4 Advantages of genetic detection of HPV for cervical cancer
4.2 Analysis of the development of the genetic testing industry from 2019 to 2023
4.2.1 Industry development stage
4.2.2 Driver analysis
4.2.3 Industry development status
4.2.4 Construction of demonstration centers
4.2.5 Industry income level
4.2.6 Industry development situation
4.3 2019-2023 Genetic Testing Market Demand Analysis
4.3.1 Market size analysis
4.3.2 Market price quotes
4.3.3 Market Pattern Analysis
4.3.4 Current situation of the consumer market
4.4 Problems in the development of the genetic testing industry
4.4.1 Analysis of major problems
4.4.2 Market chaos analysis
4.4.3 Lack of industry standards
4.5 Countermeasures for the development of the genetic testing industry
4.5.1 Suggestions for standardized development
4.5.2 Standardized management countermeasures
4.5.3 Target customer selection strategy
Chapter 5 2019-2023 China Genetic Testing Market Competitiveness and Business Model Analysis
5.1 Analysis of the competitive situation and development model of the genetic testing service market
5.1.2 Market analysis of research-grade genetic testing
5.1.3 Clinical-grade genetic testing market analysis
5.1.4 Consumer Genetic Testing Market Analysis
5.2 Analysis of the five forces competition model of the genetic testing market
5.2.1 Competition of incumbents
5.2.2 Potential Entrants
5.2.3 Threat of Substitutes
5.2.4 Bargaining power of suppliers
5.2.5 Bargaining Power of the Purchaser
5.3 The core link of the genetic testing business model
5.3.1 Relationship with Upstream Suppliers
5.3.2 Acquisition of clinical testing qualifications
5.3.3 Establishment of disease genome database
5.3.4 Sales model, hospital coverage
5.4 Analysis of the design of the business model of genetic testing
5.4.1 Customer Segmentation
5.4.2 Value Proposition
5.4.3 Channels
5.4.4 Customer Relations
5.4.5 Sources of Income
5.4.6 Core Resources
5.4.7 Business Cooperation
Chapter 6 Analysis of the development of technology and equipment in the genetic testing industry from 2019 to 2023
6.1 Development of technical equipment in the genetic testing industry
6.1.1 Main Technical Analysis
6.1.2 Technology cost analysis
6.1.3 Review of technological developments
6.1.4 Technical Application Scenarios
6.1.5 Technical Application Areas
6.2 Analysis of the development of PCR technology
6.2.1 Development process of PCR technology
6.2.2 Digital PCR industry analysis
6.2.3 Application of digital PCR technology
6.2.4 Release of digital PCR equipment
6.3 Development of gene chips
6.3.1 Introduction to gene chips
6.3.2 Types of microarray technology
6.3.3 Application fields of gene chip technology
6.3.4 Analysis of listed companies related to gene chips
6.3.5 Development prospects of gene chip technology
6.4 Development of DNA sequencing technology
6.4.1 First-generation DNA sequencing technology - Sanger strand termination
6.4.2 Second-generation DNA sequencing technology - massively parallel sequencing
6.4.3 Comparative analysis of first-generation and second-generation DNA sequencing technologies
6.4.4 Third-generation DNA sequencing technology - high-throughput, single-molecule sequencing
6.4.5 Fourth-generation DNA sequencing technology - nanopore sequencing
6.4.6 Analysis of DNA nanobiotechnology research techniques
6.5 Development trends of genetic testing technology from 2019 to 2023
6.5.1 Application of genetic testing in cardiovascular diseases
6.5.2 Genetic testing technology interprets individual genes
6.5.3 Genetic testing technology for the prevention and control of birth defects
6.5.4 Genetic testing technology assists in the treatment of hematological diseases
6.5.5 Breakthroughs have been made in gene sequencing technology
6.5.6 Enterprises carry out technical cooperation in genetic testing
6.6 Analysis of the R&D process of genetic testing equipment
6.6.1 Application requirements for portable DNA sequencers
6.6.2 Review of the development of localization of genetic testing equipment
6.6.3 Analysis of the development scale of second-generation sequencers in mainland China
6.6.4 The third-generation sequencer completes the NIPT test
6.6.5 Development trends of localization of genetic testing equipment
6.7 Introduction of some national demonstration centers for the application of genetic testing technology
6.7.1 Ningbo Genetic Testing Technology Application Demonstration Center
6.7.2 Sichuan Genetic Testing Technology Application Demonstration Center
6.7.3 Dongguan National Demonstration Center for the Application of Genetic Testing Technology
6.7.4 Gansu National Demonstration Center for the Application of Genetic Testing Technology
6.7.5 National Genetic Testing Technology Application Demonstration Center of Inner Mongolia
Chapter 7 Analysis of the Development of China's Gene Sequencing Industry
7.1 Basic overview of gene sequencing
7.1.1 Introduction to Concepts
7.1.2 Sequencing process
7.1.3 History
7.1.4 Applications
7.2 Analysis of the gene sequencing industry chain
7.2.1 Overview of the industrial chain
7.2.2 Characteristics of the industrial chain
7.2.3 Upstream of the industrial chain
7.2.4 Midstream of the industrial chain
7.3 Global Gene Sequencing Market Development Analysis
7.3.1 Analysis of the regulatory situation
7.3.2 Market development scale
7.3.3 Market Competitive Landscape
7.3.4 Market Influencing Factors
7.4 Analysis of the development of China's gene sequencing industry
7.4.1 Analysis of the Regulatory Situation
7.4.2 Development Advantage Analysis
7.4.3 Market size
7.4.4 Market Competitive Landscape
7.5 Development Trends and Prospects of the Gene Sequencing Industry
7.5.1 Market Outlook Analysis
7.5.2 Overall Development Trends
7.5.3 Industry development direction
7.5.4 App Store Outlook
Chapter 8 Analysis of the Competitiveness of Key Enterprises in China's Genetic Testing Industry
8.1 Guangzhou Daan Gene Co., Ltd
8.1.1 Overview of enterprise development
8.1.2 Analysis of business benefits
8.1.3 Business operation analysis
8.1.4 Financial Position Analysis
8.2 Dian Diagnostic Technology Group Co., Ltd
8.2.1 Enterprise development overview
8.2.2 Analysis of business benefits
8.2.3 Business operation analysis
8.2.4 Analysis of financial position
8.3 Meinian Health Industry Holdings Co., Ltd
8.3.1 Overview of enterprise development
8.3.2 Analysis of business benefits
8.3.3 Business operation analysis
8.3.4 Analysis of financial position
8.4 Shenzhen BGI Co., Ltd
8.4.1 Overview of enterprise development
8.4.2 Analysis of business benefits
8.4.3 Business operation analysis
8.4.4 Financial Analysis
8.5 Chengdu Berry Hekang Gene Technology Co., Ltd
8.5.1 Enterprise development
8.5.2 Analysis of business benefits
8.5.3 Business operation analysis
8.5.4 Analysis of financial position
8.6 Wuxi AppTec New Drug Development Co., Ltd
8.6.1 Overview of enterprise development
8.6.2 Analysis of business benefits
8.6.3 Business operation analysis
8.6.4 Analysis of financial position
8.7 Zhongyuan Concord Cell Genetic Engineering Co., Ltd
8.7.1 Overview of enterprise development
8.7.2 Analysis of operating benefits
8.7.3 Business operation analysis
8.7.4 Analysis of financial position
8.8 Beijing Hongbo Gene Medical Technology Co., Ltd
8.8.1 Overview of enterprise development
8.8.2 Analysis of business benefits
8.8.3 Business operation analysis
8.8.4 Financial Analysis
8.9 Anhui Anke Bioengineering (Group) Co., Ltd
8.9.1 Enterprise Development Overview
8.9.2 Analysis of business benefits
8.9.3 Business Analysis
8.9.4 Financial Analysis
8.10 Boao Biotech Group Co., Ltd
8.10.1 Basic information of the enterprise
8.10.2 Introduction to Main Business
8.10.3 Business conditions
8.10.4 Competitive Advantage of Enterprises
Chapter 9 Investment and Financing Analysis of China's Genetic Testing Industry from 2024 to 2030
9.1 Investment and financing analysis of the genetic testing industry
9.1.1 Analysis of financing scale
9.1.2 Distribution of Financing Rounds
9.1.3 Analysis of capital investment
9.1.4 Analysis of industrial chain financing
9.1.5 Entry Channels for Foreign Enterprises
9.2 Analysis of investment in gene sequencing industry
9.2.1 Current status of industry investment
9.2.2 Industry Investment Risk
9.2.3 Industry Investment Opportunities
9.3 Investment opportunities in the genetic testing industry
9.3.1 Investment opportunities in health management
9.3.2 Development opportunities for scientific research sequencing
9.3.3 Gene Sequencer Industry Opportunities
9.3.4 Industry Investment Advice
9.3.5 Cancer Genetic Testing Market Opportunity
9.3.6 Opportunities for consumer-grade genetic testing
9.4 Evaluation and Suggestions on Investment Opportunities in the Genetic Testing Industry
9.4.1 Comprehensive assessment of investment value
9.4.2 Market Opportunity Matrix Analysis
9.4.3 Market Entry Timing Judgment
9.4.4 Analysis of industry investment barriers
9.4.5 Industry Investment Strategy Analysis
9.4.6 Industry Investment Risk Warning
Chapter 10 Development Trends and Prospects of China's Genetic Testing Industry from 2024 to 2030
10.1 Future development trend of the genetic testing industry
10.1.1 Analysis of the overall development trend of the industry
10.1.2 Artificial intelligence (AI) has become a new technology
10.1.3 Personalized treatment has become a development trend
10.1.4 CAR-T疗法关注度趋势
10.2 Analysis of the development prospect of the genetic testing industry
10.2.1 Prospects for the genetic testing industry
10.2.2 Growth space of the genetic testing industry
10.2.3 Development ideas for the genetic testing industry
10.3 Forecast and analysis of China's genetic testing industry from 2024 to 2030
10.3.1 Analysis of influencing factors of China's genetic testing industry from 2024 to 2030
10.3.2 China Genetic Testing Market Size Forecast 2024-2030
Appendix:
Appendix 1: Specification for the Management of Gene Chip Diagnostic Technology (Trial)
Appendix II: Notice on Strengthening the Management of Products and Technologies Related to the Clinical Use of Gene Sequencing
Appendix III: Administrative Measures for the Registration of Medical Devices
Table of Contents:
Figure 1 Genetic testing industry chain
Figure 2 Global market share of genetic testing
Figure 3 Proportion of China's R&D
Figure 4 Coverage of genetic testing services
Figure 5 Testing volume of major domestic genetic testing companies in 2023
Figure 6 Forecast of the number of people in demand for genetic testing
Figure 7 Proportion of global genetic testing applications
Figure 8 GDP growth rate, 2019-2023
Figure 9 Year-on-year growth rate of China's fixed asset investment (excluding rural households) from 2019 to 2023
Figure 10 Population and composition at the end of 2023
Figure 11 Temporal distribution of genetic testing companies from 2019 to 2023
Figure 12 Evaluation of the driving factors of the development of the genetic testing industry
Figure 13 Relevant units of the first batch of genetic testing technology application demonstration centers
Figure 14 Operating profit margin of leading sequencer companies from 2019 to 2023
Figure 15 Profits of upstream and midstream companies in genetic testing from 2019 to 2023
Figure 16 Market size of China's genetic testing industry from 2019 to 2023
Figure 17 Mainstream genetic testing companies in the domestic market
Figure 18 Common product forms of genetic testing companies
Exhibit 19 Summary of product forms by major players in the market
Figure 20 Number of companies by genetic testing services segment
Figure 21 Concentration of clinical-grade genetic testing market
Figure 22 Tumor genetic testing market landscape
Figure 23 Microbial genetic testing market landscape
Figure 24 Market landscape of consumer genetic testing
Figure 25 DTC model of consumer genetic testing market
Figure 26 Comparison of genetic testing technologies
Figure 27 Whole genome sequencing cost
Figure 28 Application scenarios of genetic testing technology
Figure 29 iScanner5 product appearance
Figure 30 Sequencing schematic diagram of gene chip
See text for more charts......